novo nordisk Archives - Page 2 of 2

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

All posts tagged "novo nordisk"

Anti-Obesity Drugs: the New ‘Holy Grail’ of the Industry

Novo Nordisk Invests €2.1 Billion in Its French Plant

The Growing Rate of Obesity: a Goldmine of 30 Billion for Novo Nordisk and Eli Lilly

Novo Nordisk Plans to Open a Tech Headquarters in Spain

Inflation Keeps the Executives of GSK, Novartis, and Roche Up at Night

What Happened Lately in the Biotech Sector

Novo Nordisk Introduces Norditropin Nordiflex, a Device for Growth Hormone Administration

CEO Spotlight: Novo Nordisk’s Lars Sørensen